Aspirin Compared With Other Anticoagulants for Use As Venous Thromboembolism Prophylaxis in Elective Orthopaedic Hip and Knee Operations: A Narrative Literature Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Oct 25

PMID 34692356

Authors

Olatomiwa Olukoya

Joshua Fultang

Affiliations

Soon will be listed here.

Abstract

Although total hip and knee arthroplasty are effective methods for treating arthritis, they have an associated risk of venous thromboembolism (VTE). To reduce this risk, prophylactic agents including aspirin, low-molecular-weight Heparin, vitamin K antagonists, and direct oral anticoagulants are employed for up to 35 days after surgery. This narrative literature review utilised a systematic approach to critically assess the current evidence surrounding the use of aspirin for VTE prophylaxis compared to anticoagulants. An advanced multistage electronic search was performed in May 2021 using the OVID/Medline and Embase online libraries to identify available studies relevant to the subject from 1974. Additional studies identified during the review process were also included. The final studies meeting the inclusion criteria were then assessed using the Critical Appraisal Skills Programme tool. A total of 12 (60%) studies (two meta-analyses, three randomised trials, seven retrospective studies) favoured aspirin over anticoagulants for VTE prophylaxis. A total of 15 (75%) studies (two meta-analyses, three randomised trials, nine retrospective, one matched cohort) reported that aspirin had better bleeding profiles and complication rates, which was statistically significant in seven (46.7%) studies (one randomised trial, six retrospective studies). A total of eight studies (one randomised trial, six retrospective studies, one matched cohort) reported statistically significant results for aspirin. Five (62.5%) studies reported aspirin to be superior for VTE prophylaxis, while seven (87.5%) reported aspirin to be superior in terms of bleeding complications. The current evidence indicates that aspirin is superior to anticoagulants, in their various iterations, for VTE prophylaxis in terms of their bleeding profiles.

References

Anderson D, Dunbar M, Murnaghan J, Kahn S, Gross P, Forsythe M . Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018; 378(8):699-707. DOI: 10.1056/NEJMoa1712746. View

Drescher F, Sirovich B, Lee A, Morrison D, Chiang W, Larson R . Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis. J Hosp Med. 2014; 9(9):579-85. DOI: 10.1002/jhm.2224. View

Learmonth I, Young C, Rorabeck C . The operation of the century: total hip replacement. Lancet. 2007; 370(9597):1508-19. DOI: 10.1016/S0140-6736(07)60457-7. View

Bala A, Murasko M, Burk D, Huddleston 3rd J, Goodman S, Maloney W . Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?. Hip Int. 2019; 30(5):564-571. DOI: 10.1177/1120700019841600. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMC: 8008539. DOI: 10.1186/s13643-021-01626-4. View

. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. J Arthroplasty. 2011; 27(1):1-9.e2. DOI: 10.1016/j.arth.2011.03.032. View

Nielen J, Dagnelie P, Emans P, Veldhorst-Janssen N, Lalmohamed A, van Staa T . Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements. Pharmacoepidemiol Drug Saf. 2016; 25(11):1245-1252. DOI: 10.1002/pds.4089. View

Matharu G, Kunutsor S, Judge A, Blom A, Whitehouse M . Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2020; 180(3):376-384. PMC: 7042877. DOI: 10.1001/jamainternmed.2019.6108. View

Bawa H, Weick J, Dirschl D, Luu H . Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty. J Am Acad Orthop Surg. 2018; 26(19):698-705. DOI: 10.5435/JAAOS-D-17-00235. View

10.

Anderson D, Dunbar M, Bohm E, Belzile E, Kahn S, Zukor D . Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013; 158(11):800-6. DOI: 10.7326/0003-4819-158-11-201306040-00004. View

11.

An V, Phan K, Levy Y, Bruce W . Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2016; 31(11):2608-2616. DOI: 10.1016/j.arth.2016.04.004. View

12.

Chu J, Maselli J, Auerbach A, Fang M . The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res. 2017; 155:65-71. PMC: 5531185. DOI: 10.1016/j.thromres.2017.04.012. View

13.

Brown G . Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials. J Arthroplasty. 2009; 24(6 Suppl):77-83. DOI: 10.1016/j.arth.2009.06.002. View

14.

Lotke P, PALEVSKY H, Keenan A, Meranze S, STEINBERG M, Ecker M . Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996; (324):251-8. DOI: 10.1097/00003086-199603000-00031. View

15.

Hasan S, Sunter W, Ahmed N, Dawoud D, Zaidi S . Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes. Int J Clin Pharm. 2020; 43(3):621-628. PMC: 8214589. DOI: 10.1007/s11096-020-01173-3. View

16.

Hood B, Cowen M, Zheng H, Hughes R, Singal B, Hallstrom B . Association of Aspirin With Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Compared With Other Anticoagulants: A Noninferiority Analysis. JAMA Surg. 2018; 154(1):65-72. PMC: 6439863. DOI: 10.1001/jamasurg.2018.3858. View

17.

Jameson S, Charman S, Gregg P, Reed M, van der Meulen J . The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry. J Bone Joint Surg Br. 2011; 93(11):1465-70. DOI: 10.1302/0301-620X.93B11.27622. View

18.

Jameson S, Baker P, Charman S, Deehan D, Reed M, Gregg P . The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data. J Bone Joint Surg Br. 2012; 94(7):914-8. DOI: 10.1302/0301-620X.94B7.29129. View

19.

Colleoni J, Ribeiro F, Mos P, Reis J, Oliveira H, Miura B . Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin rivaroxaban. Rev Bras Ortop. 2018; 53(1):22-27. PMC: 5771791. DOI: 10.1016/j.rboe.2017.11.007. View

20.

Zou Y, Tian S, Wang Y, Sun K . Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis. 2014; 25(7):660-4. DOI: 10.1097/MBC.0000000000000121. View